Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1983 1
1984 3
1985 1
1986 5
1987 6
1988 3
1989 1
1990 9
1991 6
1992 11
1993 10
1994 11
1995 13
1996 14
1997 10
1998 4
1999 2
2000 4
2001 5
2002 7
2003 10
2004 7
2005 11
2006 9
2007 9
2008 5
2009 8
2010 6
2011 10
2012 9
2013 18
2014 6
2015 8
2016 13
2017 9
2018 6
2019 5
2020 5
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

263 results
Results by year
Filters applied: . Clear all
Page 1
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC.
Manegold C, Dingemans AC, Gray JE, Nakagawa K, Nicolson M, Peters S, Reck M, Wu YL, Brustugun OT, Crinò L, Felip E, Fennell D, Garrido P, Huber RM, Marabelle A, Moniuszko M, Mornex F, Novello S, Papotti M, Pérol M, Smit EF, Syrigos K, van Meerbeeck JP, van Zandwijk N, Yang JC, Zhou C, Vokes E. Manegold C, et al. Among authors: van zandwijk n. J Thorac Oncol. 2017 Feb;12(2):194-207. doi: 10.1016/j.jtho.2016.10.003. Epub 2016 Oct 8. J Thorac Oncol. 2017. PMID: 27729297 Free article. Review.
Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.
Majewski IJ, Mittempergher L, Davidson NM, Bosma A, Willems SM, Horlings HM, de Rink I, Greger L, Hooijer GK, Peters D, Nederlof PM, Hofland I, de Jong J, Wesseling J, Kluin RJ, Brugman W, Kerkhoven R, Nieboer F, Roepman P, Broeks A, Muley TR, Jassem J, Niklinski J, van Zandwijk N, Brazma A, Oshlack A, van den Heuvel M, Bernards R. Majewski IJ, et al. Among authors: van zandwijk n. J Pathol. 2013 Jul;230(3):270-6. doi: 10.1002/path.4209. J Pathol. 2013. PMID: 23661334
Editorial: Emerging Therapies for Malignant Mesothelioma.
van Zandwijk N, Reid G, Baas P. van Zandwijk N, et al. Front Oncol. 2020 Jun 12;10:939. doi: 10.3389/fonc.2020.00939. eCollection 2020. Front Oncol. 2020. PMID: 32596157 Free PMC article. No abstract available.
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G; European Organisation for Research and Treatment of Cancer-Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van zandwijk n. J Natl Cancer Inst. 2007 Mar 21;99(6):442-50. doi: 10.1093/jnci/djk093. J Natl Cancer Inst. 2007. PMID: 17374834 Free article. Clinical Trial.
The COVID-19 outbreak: a snapshot from down under.
van Zandwijk N, Rasko JEJ. van Zandwijk N, et al. Expert Rev Anticancer Ther. 2020 Jun;20(6):433-436. doi: 10.1080/14737140.2020.1766974. Epub 2020 May 18. Expert Rev Anticancer Ther. 2020. PMID: 32419533 No abstract available.
Potential toxicities of carbon nanotubes: time for a reminder.
van Zandwijk N, Frank AL. van Zandwijk N, et al. Expert Rev Respir Med. 2020 Apr;14(4):339-340. doi: 10.1080/17476348.2020.1715213. Epub 2020 Jan 14. Expert Rev Respir Med. 2020. PMID: 31920124 No abstract available.
Awareness: potential toxicities of carbon nanotubes.
van Zandwijk N, Frank AL. van Zandwijk N, et al. Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S471-S472. doi: 10.21037/tlcr.2019.12.05. Transl Lung Cancer Res. 2019. PMID: 32038941 Free PMC article. No abstract available.
Malignant mesothelioma.
Kao SC, Reid G, Lee K, Vardy J, Clarke S, van Zandwijk N. Kao SC, et al. Among authors: van zandwijk n. Intern Med J. 2010 Nov;40(11):742-50. doi: 10.1111/j.1445-5994.2010.02223.x. Intern Med J. 2010. PMID: 20298508 Review.
263 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page